Blood-based biomarkers in Alzheimer’s disease: an overview on proteomic and lipidomic approaches
Alzheimer’s disease (AD) remains one of the most challenging pathologies since its etiology is not completely known, its progression is slow and there are no disease-changing pharmacological agents available yet. One other important characteristic is that the progression of AD pathology starts long...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sciendo
2016-06-01
|
| Seri Bilgileri: | Romanian Journal of Laboratory Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1515/rrlm-2016-0017 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|